Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 92337C203 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Deep Track Capital, LP
13G
|
10.0% |
11/21/2025
Event 11/14/2025
|
||
| Deep Track Capital, LP | 10.0% | |||
| Deep Track Biotechnology Master Fund, Ltd. | 10.0% | |||
| David Kroin | 10.0% | |||
|
RTW Investments, LP
13G/A
|
9.9% |
5/15/2026
Event 3/31/2026
|
||
| RTW Investments, LP | 9.9% | |||
| Roderick Wong | 9.9% | |||
|
Armistice Capital, LLC
13G/A
|
7.8% |
8/14/2026
Event 6/30/2026
|
||
| Armistice Capital, LLC | 7.8% | |||
| Steven Boyd | 7.8% | |||
|
Soleus Capital Master Fund, L.P.
13G/A
|
7.3% |
2/11/2025
Event 12/31/2024
|
||
| Soleus Private Equity Fund III, L.P. | 3.9% | |||
| Soleus Private Equity GP III, LLC | 3.9% | |||
| Soleus PE GP III, LLC | 3.9% | |||
| Soleus Capital Master Fund, L.P. | 3.5% | |||
| Soleus Capital, LLC | 3.5% | |||
| Soleus Capital Group, LLC | 3.5% | |||
| Soleus Capital Management, L.P. | 7.3% | |||
| Soleus GP LLC | 7.3% | |||
| Guy Levy | 7.3% | |||
| BlackRock, Inc. 13G/A | 7.0% |
7/30/2026
Event 6/30/2026
|
||
| State Street Corp 13G | 5.8% |
8/7/2026
Event 6/30/2026
|
||
| Vanguard Capital Management LLC 13G | 5.0% |
7/31/2026
Event 6/30/2026
|
||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (14) | ||||
|
Polar Capital Holdings Plc
13G/A
|
4.8% |
7/8/2026
Event 3/31/2026
|
||
| Polar Capital Holdings Plc | 4.8% | |||
| Polar Capital LLP | 4.8% | |||
| Polar Capital Funds PLC - Biotechnology Fund | 4.8% | |||
|
Logos Global Management LP
13G/A
|
4.8% |
11/14/2025
Event 9/30/2025
|
||
| Logos Global Management LP | 4.8% | |||
| Logos Global Management GP LLC | 4.8% | |||
| Logos Global Master Fund LP | 4.8% | |||
| Logos GP LLC | 4.8% | |||
| Arsani William | 4.8% | |||
|
Nantahala Capital Management, LLC
13G/A
|
4.7% |
2/13/2026
Event 12/31/2025
|
||
| Nantahala Capital Management, LLC | 4.7% | |||
| Wilmot B. Harkey | 4.7% | |||
| Daniel Mack | 4.7% | |||
|
Stonepine Capital Management, LLC
13G/A
|
4.3% |
11/13/2025
Event 9/30/2025
|
||
| Stonepine Capital Management, LLC | 4.3% | |||
| Stonepine Capital, L.P. | 4.3% | |||
| Stonepine GP, LLC | 4.3% | |||
| Jon M. Plexico | 4.3% | |||
|
Biotechnology Value Fund L P
13G/A
|
3.9% |
8/13/2025
Event 8/11/2025
|
||
| Biotechnology Value Fund L P | 2.2% | |||
| BVF I GP LLC | 2.2% | |||
| Biotechnology Value Fund II LP | 1.5% | |||
| BVF II GP LLC | 1.5% | |||
| Biotechnology Value Trading Fund OS LP | 0.2% | |||
| BVF Partners OS Ltd. | 0.2% | |||
| BVF GP Holdings LLC | 3.6% | |||
| BVF Partners L P/IL | 3.9% | |||
| BVF Inc/IL | 3.9% | |||
| Lampert Mark N | 3.9% | |||
|
Foresite Capital Fund VI LP
13G/A
|
3.6% |
5/15/2026
Event 3/31/2026
|
||
| Foresite Capital Fund VI LP | 3.6% | |||
| Foresite Capital Management VI LLC | 3.6% | |||
| Tananbaum James B. | 3.6% | |||
|
Orin Hirschman
13G/A
|
3.6% |
7/29/2025
Event 6/30/2025
|
||
| Orin Hirschman | 3.6% | |||
| AIGH Capital Management LLC | 3.6% | |||
| Orbimed Advisors LLC 13G/A | 2.4% |
8/14/2025
Event 6/30/2025
|
||
|
Alyeska Investment Group, L.P.
13G/A
|
2.1% |
2/14/2025
Event 12/31/2024
|
||
| Alyeska Investment Group, L.P. | 2.1% | |||
| Alyeska Fund GP, LLC | 2.1% | |||
| Anand Parekh | 2.1% | |||
|
Soleus Private Equity Fund III, L.P.
13G/A
|
1.8% |
5/2/2025
Event 3/31/2025
|
||
| Soleus Private Equity Fund III, L.P. | 0.7% | |||
| Soleus Private Equity GP III, LLC | 0.7% | |||
| Soleus PE GP III, LLC | 0.7% | |||
| Soleus Capital Master Fund, L.P. | 1.2% | |||
| Soleus Capital, LLC | 1.2% | |||
| Soleus Capital Group, LLC | 1.2% | |||
| Soleus Capital Management, L.P. | 1.8% | |||
| Soleus GP, LLC | 1.8% | |||
| Guy Levy | 1.8% | |||
|
Balyasny Asset Management L.P.
13G/A
|
1.6% |
5/15/2026
Event 3/31/2026
|
||
| Balyasny Asset Management L.P. | 1.6% | |||
| Bam GP LLC | 1.6% | |||
| Balyasny Asset Management Holdings LP | 1.6% | |||
| Dames GP LLC | 1.6% | |||
| Dmitry Balyasny | 1.6% | |||
|
Point72 Asset Management, L.P.
13G/A
|
1.3% |
2/17/2026
Event 12/31/2025
|
||
| Point72 Asset Management, L.P. | 1.3% | |||
| Point72 Capital Advisors, Inc. | 1.3% | |||
| Steven A. Cohen | 1.3% | |||
| Vanguard Group Inc 13G/A | 0% |
3/27/2026
Event 3/13/2026
|
||
| Barclays PLC 13G/A |
Checked 5% or less
|
8/12/2025
Event 6/30/2025
|
||
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 3 | 1.16 k | $9.31 k |
| 2026 Q2 | 169 | 98.9 M | $379 M |
| 2026 Q1 | 163 | 81.4 M | $432 M |
| 2025 Q4 | 151 | 76.5 M | $591 M |
| 2025 Q3 | 126 | 59.6 M | $527 M |
| 2025 Q2 | 119 | 53.0 M | $220 M |
| 2025 Q1 | 105 | 43.3 M | $261 M |
| 2024 Q4 | 95 | 35.4 M | $181 M |
| 2024 Q3 | 82 | 26.6 M | $80.4 M |
| 2024 Q2 | 75 | 15.2 M | $45.2 M |
| 2024 Q1 | 77 | 17.0 M | $201 M |
| 2023 Q4 | 63 | 16.8 M | $137 M |
| 2023 Q3 | 60 | 16.8 M | $136 M |
| 2023 Q2 | 64 | 16.1 M | $120 M |